J 2020

Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group

VERBRUGGEN, L. C., Y. H. WANG, S. H. ARMENIAN, M. J. EHRHARDT, H. J. H. VAN DER PAL et. al.

Basic information

Original name

Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group

Authors

VERBRUGGEN, L. C. (528 Netherlands, guarantor), Y. H. WANG (528 Netherlands), S. H. ARMENIAN (840 United States of America), M. J. EHRHARDT (840 United States of America), H. J. H. VAN DER PAL (528 Netherlands), E. C. VAN DALEN (528 Netherlands), J. W. VAN AS (528 Netherlands), E . BARDI (40 Austria), K. BAUST (276 Germany), C. BERGER (250 France), E. CASTAGNOLA (380 Italy), K. A. DEVINE (840 United States of America), J . GEBAUER (276 Germany), J. G. MARCHAK (840 United States of America), A. W. GLASER (826 United Kingdom of Great Britain and Northern Ireland), A. H. GROLL (276 Germany), G. M. HAEUSLER (36 Australia), J. DEN HARTOGH (528 Netherlands), R. HAUPT (380 Italy), L. HJORTH (752 Sweden), M. KATO (392 Japan), Tomáš KEPÁK (203 Czech Republic, belonging to the institution), M. M. W. KOOPMAN (528 Netherlands), T. LANGER (276 Germany), M. MAEDA (392 Japan), G. MICHEL (756 Switzerland), M. MURACA (380 Italy), P. C. NATHAN (124 Canada), S. R. VAN DEN OEVER (528 Netherlands), V. PAVASOVIC (826 United Kingdom of Great Britain and Northern Ireland), S. SATO (392 Japan), F. SCHULTE (124 Canada), L. L. SUNG (124 Canada), W. TISSING (528 Netherlands), A. UYTTEBROECK (56 Belgium), R. L. MULDER (528 Netherlands), C. KUEHNI (756 Switzerland), R. SKINNER (826 United Kingdom of Great Britain and Northern Ireland), M. M. HUDSON (840 United States of America) and L. C. M. KREMER (528 Netherlands)

Edition

PEDIATRIC BLOOD & CANCER, HOBOKEN, WILEY, 2020, 1545-5009

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30209 Paediatrics

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 3.167

RIV identification code

RIV/00216224:14110/20:00116603

Organization unit

Faculty of Medicine

UT WoS

000572077700001

Keywords in English

childhood adolescent and young adult (CAYA) cancer survivors; COVID-19; late effects of cancer treatment

Tags

Tags

International impact, Reviewed
Změněno: 5/1/2021 13:30, Mgr. Tereza Miškechová

Abstract

V originále

Childhood, adolescent, and young adult (CAYA) cancer survivors may be at risk for a severe course of COVID-19. Little is known about the clinical course of COVID-19 in CAYA cancer survivors, or if additional preventive measures are warranted. We established a working group within the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG) to summarize existing evidence and worldwide recommendations regarding evidence about factors/conditions associated with risk for a severe course of COVID-19 in CAYA cancer survivors, and to develop a consensus statement to provide guidance for healthcare practitioners and CAYA cancer survivors regarding COVID-19.